Erytech Pharma SA - Delisted Stock
Erytech Pharma SA is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Erytech Pharma was actively traded.
Valuation
Check how we calculate scores
Erytech Pharma SA Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Erytech Pharma market risk premium is the additional return an investor will receive from holding Erytech Pharma long position in a well-diversified portfolio.
Mean Deviation | 4.72 | |||
Standard Deviation | 7.09 | |||
Variance | 50.23 | |||
Risk Adjusted Performance | 9.0E-4 |
View Erytech Pharma Related Equities
Risk & Return | Correlation |
Erytech Pharma Corporate Management
Gil BVBA | CEO Director | Profile | |
Iman MD | Chief Officer | Profile | |
Philip Lorenzi | Consultant Board | Profile | |
AnneCcile Fumey | HR Director | Profile | |
Brian Schwab | Chief Counsel | Profile | |
Naomi Eichenbaum | Director Relations | Profile |
Still Interested in Erytech Pharma SA?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Erytech Stock
If you are still planning to invest in Erytech Pharma SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Erytech Pharma's history and understand the potential risks before investing.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |